Cart
sales@molnova.com
KX2-361
CAS No. 897016-26-1
KX2-361 ( KX-2361;KX-02 )
Catalog No. M16453 CAS No. 897016-26-1
KX2-361 (KX 02) is a potent, dual Src signaling/tubulin polymerization inhibitor that are under clinical evaluation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | 1368 | Get Quote |
|
| 500MG | 2673 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKX2-361
-
NoteResearch use only, not for human use.
-
Brief DescriptionKX2-361 (KX 02) is a potent, dual Src signaling/tubulin polymerization inhibitor that are under clinical evaluation.
-
DescriptionKX2-361 (KX 02) is a potent, dual Src signaling/tubulin polymerization inhibitor that are under clinical evaluation.Brain Cancer Phase 1 Clinical
-
SynonymsKX-2361;KX-02
-
PathwayAngiogenesis
-
TargetSrc
-
RecptorSrc
-
Research AreaCancer
-
IndicationBrain Cancer
Chemical Information
-
CAS Number897016-26-1
-
Formula Weight405.47
-
Molecular FormulaC24H24FN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCC1=CC=CC(F)=C1)CC2=NC=C(C3=CC=C(N4CCOCC4)C=C3)C=C2
-
Chemical NameN-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl)pyridin-2-yl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Smolinski MP, et al. J Med Chem. 2018 Apr 17. doi: 10.1021/acs.jmedchem.8b00164.
molnova catalog
related products
-
Saracatinib
A potent, highly selective, orally available, dual Src/Abl kinase inhibitor with IC50 of 2.7, 4, 4 and 30 nM for c-Src, Yes, Lck and Abl, respectively.
-
AZ12672857
AZ12672857 is an inhibitor of EphB4 with IC50 of 1.3 nM. AZ12672857 inhibits cell proliferation of Src transfected 3T3 cells with IC50 of 2 nM and autophosphorylation of EphB4 in transfected CHO-K1 cells with IC50 of 9 nM.
-
WAY-303290
WAY-303290 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain.
